"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

About half of people with "chronic spontaneous urticaria," or CSU, the most common type of chronic hives, experience what ...

Urticaria affects 10% to 25% of the population at some point in their life (Henderson, Fleischer, & Feldman, 2000). It is characterized by short-lived swellings of the skin, mouth, and genitalia ...

Treatment options for urticaria depend on the type of urticaria and the severity of symptoms. “Treatment typically follows a ...

to treat adults and pediatric patients aged 12 years and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 antihistamine treatment. The target ...

Overall rates of treatment-emergent adverse events were ... will provide another therapeutic option for patients with chronic urticaria unresponsive to antihistamines,” Casale commented.

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...